BET Proteins: An Approach to Future Therapies in Transplantation-Reference-Cited by-同舟云学术

BET Proteins: An Approach to Future Therapies in Transplantation

Published:2017-03-10 Issue:9 Volume:17 Page:2254-2262
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Suarez-Alvarez B.¹,Rodriguez R. M.¹,Ruiz-Ortega M.²,Lopez-Larrea C.¹

Affiliation:

1. Department of Immunology; Hospital Universitario Central de Asturias; Oviedo Spain

2. Cellular Biology of Renal Disease Laboratory; Nephrology Department; Instituto de Investigación Sanitaria Fundación Jiménez Díaz; Universidad Autónoma de Madrid; Madrid Spain

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14221/fullpdf

Reference65 articles.

1. A brief history of epigenetics;Felsenfeld;Cold Spring Harb Perspect Biol,2014

2. Epigenetic modifications and human disease;Portela;Nat Biotechnol,2010

3. Epigenetic modulation of the immune function: A potential target for tolerance;Suárez-Alvarez;Epigenetics,2013

4. The emerging role of DNA methylation in kidney transplantation: A perspective;Heylen;Am J Transplant,2016

5. Epigenetics in kidney transplantation: Current evidence, predictions, and future research directions;Mas;Transplantation,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection;PLOS Pathogens;2023-09-25

2. Combination Epigenetic Therapy;Handbook of Epigenetics;2023

3. Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism;2022-09-23

4. A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles;Frontiers in Pharmacology;2022-03-25

5. Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development;Journal of Medicinal Chemistry;2022-03-24